Skip to Content

Fresenius Medical Care AG ADR FMS

Morningstar Rating
$19.69 +0.32 (1.65%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Price vs Fair Value

FMS is trading at a 39% discount.
Price
$19.37
Fair Value
$84.00
Uncertainty
High
1-Star Price
$98.80
5-Star Price
$16.70
Economic Moat
Fzxgzx
Capital Allocation
Ybwg

Bulls Say, Bears Say

Bulls

Diversified by geography and business mix, Fresenius should be able to benefit from ongoing growth in treating ESRD patients worldwide once the pandemic recedes.

Bears

With virtually all of its U.S. service profits coming from commercial insurance, Fresenius' profits could contract in several potential policy scenarios.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FMS is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$19.37
Day Range
$19.6619.89
52-Week Range
$16.3727.72
Bid/Ask
$18.00 / $20.67
Market Cap
$11.55 Bil
Volume/Avg
323,382 / 406,533

Key Statistics

Price/Earnings (Normalized)
14.36
Price/Sales
0.60
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
Sector
Healthcare
Industry
Medical Care Facilities
Stock Style Box
Mid Value
Total Number of Employees
119,845

Competitors

Valuation

Metric
FMS
DVA
BAX
Price/Earnings (Normalized)
14.3614.7314.68
Price/Book Value
0.8410.382.39
Price/Sales
0.600.951.35
Price/Cash Flow
5.796.1713.99
Price/Earnings
FMS
DVA
BAX

Financial Strength

Metric
FMS
DVA
BAX
Quick Ratio
0.921.060.91
Current Ratio
1.421.191.48
Interest Coverage
3.223.950.66
Quick Ratio
FMS
DVA
BAX

Profitability

Metric
FMS
DVA
BAX
Return on Assets (Normalized)
2.46%6.40%4.63%
Return on Equity (Normalized)
6.26%112.35%19.64%
Return on Invested Capital (Normalized)
3.93%10.05%6.97%
Return on Assets
FMS
DVA
BAX
See how this stock stacks up to its competitors with Morningstar Investor

Medical Care Facilities Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
HCA
HCA Healthcare IncGclqpcs$83.4 Bil
FSNUF
Fresenius SE & Co KGaAYwmcq$15.6 Bil
FSNUY
Fresenius SE & Co KGaA ADRFytmgp$15.6 Bil
BDULF
Bangkok Dusit Medical Services PCL Shs Foreign RegisteredJqpcg$13.0 Bil
JDHIF
JD Health International IncQwmpzd$12.5 Bil
JDHIY
JD Health International Inc ADRYvjptgc$12.5 Bil
DVA
DaVita IncNtfnpj$10.9 Bil
THC
Tenet Healthcare CorpMcyq$9.3 Bil
AMN
AMN Healthcare Services IncKqchpg$2.1 Bil

Sponsor Center